跳至主要内容
临床试验/NCT00865501
NCT00865501已完成3 期

Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease

University of Erlangen-Nürnberg Medical School1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
left ventricular mass

研究概览

简要总结

The Renin-Angiotensin-Aldosterone-system is important in the development of cardiovascular organ damage caused by arterial hypertension. This study aims at evaluating the importance of aldosterone with regard to hypertension induced damage to the heart. In order to do this the investigators will perform a comparative cross-sectional study in hypertensives and normotensives. In addition as interventional part the hypertensives will be treated with a mineralocorticoid-receptor blocker (spironolactone).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Clinical diagnosis hypertension (BP higher than 139/89)

排除标准

  • Antihypertensive pretreatment
  • Contraindications against spironolactone
  • Being unable to understand or comply with study procedures

研究组 & 干预措施

1

Experimental

spironolactone

干预措施: spironolactone (Drug)

2

Placebo Comparator

placebo

干预措施: placebo (Drug)

结局指标

主要结局

left ventricular mass

时间窗: 8 weeks

次要结局

未报告次要终点

研究者

发起方
University of Erlangen-Nürnberg Medical School
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Importance of Aldosterone in the Pathogenesis of... | 临床试验